Text and Data Mining valid from 2018-09-28
Received: 21 March 2018
Revised: 13 July 2018
Accepted: 14 August 2018
First Online: 28 September 2018
Compliance with ethical standards
: The scientific guarantor of this publication is Diomidis Botsikas. MD, Privat Docent (PD).
: All authors declare no conflict of interest.
: One of the authors has significant statistical expertise.No complex statistical methods were necessary for this article.
: Written informed consent was obtained from all subjects (patients) in this study.
: Institutional Review Board approval was obtained.
: Data of PET/MR examinations of 42 patients were included in the article below. This article focused on the diagnostic performance of PET/MR in loco-regional staging of breast cancer and data of PET/CT were not analysed. This same article also included PET/MR after neoadjuvant systemic treatment while the present manuscript includes only data from the initial PET/MR study.Clinical utility of 18F-FDG-PET/MR for preoperative breast cancer staging. Botsikas D, Kalovidouri A, Becker M, Copercini M, Djema DA, Bodmer A, Monnier S, Becker CD, Montet X, Delattre BM, Ratib O, Garibotto V, Tabouret-Viaud C. Eur Radiol. 2016 Jul;26(7):2297-307. doi: 10.1007/s00330-015-4054-z. Epub 2015 Oct 17.
: • prospective• diagnostic or prognostic study• performed at one institution